SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Healthcare >

Mylan Inc. (MYL)

MYL RSS Feed
Add MYL Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board: 
Last Post: 9/1/2017 7:35:07 PM - Followers: 13 - Board type: Free - Posts Today: 0
SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
MYL
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
MYL News: Mylan Expands Women's Healthcare Portfolio with Launch of Generic Minastrin® 24 FE Tablets 09/14/2017 12:03:00 PM
MYL News: Mylan Names Dennis Zeleny as Chief Human Relations Officer 09/13/2017 08:00:00 AM
MYL News: Otsuka and Mylan Announce License Agreement to Commercialize Delamanid (Deltyba™) for Multidrug-Resistant Tuberculosis (MDR... 08/24/2017 03:00:00 AM
MYL News: Current Report Filing (8-k) 08/21/2017 05:20:08 PM
MYL News: Mylan Finalizes Settlement Agreement on Medicaid Rebate Classification for EpiPen® Auto-Injector 08/17/2017 10:43:00 AM
PostSubject
#80  Sticky Note MYL 2Q17 results… DewDiligence 08/09/17 09:30:58 AM
#85   MYL takeover bid? More info would be great. INTL 09/01/17 07:35:07 PM
#84   Link? DewDiligence 08/24/17 08:59:27 AM
#83   An initiated source fully reliable has revealed that carlosorion 08/23/17 11:48:35 PM
#82   https://seekingalpha.com/article/4098690-mylan-suffers-jet-lag Inoviorulez 08/14/17 03:57:01 PM
#81   MYL removes Copaxone from 2017 guidance. (Source: Today’s DewDiligence 08/09/17 10:14:12 AM
#80   MYL 2Q17 results… DewDiligence 08/09/17 09:30:58 AM
#79   MYL gets split decisions on Herceptin FoB: DewDiligence 07/14/17 03:15:03 PM
#78   MYL SRI 5 TREND1 05/24/17 01:15:15 PM
#77   MYL 1Q17 results: DewDiligence 05/10/17 10:16:39 AM
#76   Perrigo Says Investigators Searched Its Offices in Generic-Drug Probe abcd12 05/03/17 10:05:55 AM
#75   https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm550170.htm?source= mikekrane 03/31/17 07:13:29 PM
#74   Who's throwing money at this wall at 40.00? foregunst 03/30/17 02:21:09 PM
#73   This failed FDA and sold tainted product Whos buying? foregunst 03/30/17 01:38:28 PM
#72   MYL Don't understand why not down 15 added foregunst 03/30/17 01:25:57 PM
#71   MYL -3% on CRL for generic Advair: DewDiligence 03/29/17 03:13:32 PM
#70   ABT pares MYL stake: #msg-129833882. DewDiligence 03/24/17 10:19:13 AM
#69   MYL 3/1/17 Investor Day slides (132 pages): DewDiligence 03/04/17 03:59:23 PM
#68   Teva Pharmaceutical Industries Ltd, Mylan NV Accused Of trendmkr 03/02/17 01:13:35 PM
#67   MYL +7% on 4Q16 results /2017 guidance: DewDiligence 03/01/17 01:40:58 PM
#66   MYL is holding an Investor Day webcast on DewDiligence 02/11/17 12:24:43 PM
#65   Citi downgraded Mylan today but EBITDA multiples trading ValueInvestor15 01/05/17 10:58:13 AM
#64   MYL launches authorized-generic EpiPen at 50% off the DewDiligence 12/17/16 05:15:27 PM
#63   MYL cutting 3,000 jobs—9% of global workforce: DewDiligence 12/08/16 07:46:57 PM
#62   MYL obtains IPRs on several Restatis patents: DewDiligence 12/08/16 07:44:11 PM
#61   There's no mention of Mabion in MYL's just-filed DewDiligence 11/11/16 01:02:20 PM
#60   Mylan Partnership Means the Race is Back on trendmkr 11/11/16 12:57:00 PM
#59   I just got in and like it going rayank 10/17/16 09:53:35 AM
#58   Raymond James upgraded Mylan $ MYL to Strong-Buy today. ValueInvestor15 10/10/16 04:32:00 PM
#57   $LPCN $5.75 gapping up p/m on Winning Patent ClearlyStocks 10/10/16 07:16:57 AM
#56   LOLOLOL 25M SHORTS MUST COVER HandyMan2000 10/07/16 06:12:15 PM
#55   MYL settles USDoJ EpiPen suit for $465M and DewDiligence 10/07/16 05:00:04 PM
#54   MYL is going down quick. Once the DOJ realnewb 09/29/16 12:33:14 AM
#53   Looks like another scammer CEO about to go ChannelTrader 09/21/16 06:50:27 PM
#52   LOL, the CEO dumped 5 million worth of Sonic Boom 08/29/16 06:06:59 PM
#50   MYL/MNTA/NVS prevail against TEVA in USPTO ruling on DewDiligence 08/25/16 10:09:19 AM
#49   Note—MYL has two FoB partners: Biocon (#msg-72421544, #msg-84561737) DewDiligence 08/25/16 10:07:36 AM
#48   MYL/Biocon submit EU MAA for Herceptin FoB: DewDiligence 08/25/16 10:04:54 AM
#47   MYL expands EpiPen patient-assistance program—in response to political pressure: DewDiligence 08/25/16 10:03:37 AM
#46   CEO's father is Sen.Joe Manchin... Nabbbss 08/25/16 09:58:52 AM
#45   One of the worst management .. Didn't sell jones99 08/24/16 05:06:16 AM
#44   expect some suits coming or halt in trading. mick 08/22/16 01:38:35 PM
#43   MYL +3% on ADMP mishap: #msg-123113344. DewDiligence 06/06/16 10:46:05 AM
#42   MYL’s generic Advair has a GDUFA date of 3/28/17: DewDiligence 02/19/16 11:50:08 AM
#41   Movers and Shakers in Biotech: One Up, One nyctraydr 02/12/16 11:26:43 AM
#40   Musings on the Meda deal: #msg-120479404. DewDiligence 02/11/16 08:01:26 PM
#39   $MYL Channel Trading $41. Which was is it runningwithscissors 02/11/16 01:22:25 PM
#38   Mylan Labs’ ($MYL) fourth quarter results missed expectations jones99 02/11/16 09:25:25 AM
#37   MYL acquires Meda: #msg-120456111. DewDiligence 02/10/16 07:18:19 PM
#36   MYL submits ANDA for generic Advair: DewDiligence 01/12/16 11:17:03 AM
#35   MYL-MNTA FoB partnerhsip is fully separate from MYL's DewDiligence 01/09/16 10:37:52 AM
PostSubject